Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02847234
Other study ID # 69HCL16_0500
Secondary ID
Status Recruiting
Phase N/A
First received July 25, 2016
Last updated July 25, 2016
Start date January 2015
Est. completion date December 2016

Study information

Verified date July 2016
Source Hospices Civils de Lyon
Contact Thomas Rimmelé, MD PhD
Phone (0)4 72 11 69 88
Email thomas.rimmele@chu-lyon.fr
Is FDA regulated No
Health authority France: Commission nationale de l'informatique et des libertés
Study type Observational

Clinical Trial Summary

Cervical necrotizing fasciitis (CNF) is a rare but severe complication of pharyngeal or dental infections. The infection can rapidly descend into the mediastinum and lead to a life-threatening prognosis. Treatment consists of a multidisciplinary approach in intensive care with radiologist and with early and repeated surgical debridement. Anti-inflammatory drugs have been incriminated by authors in the development of necrotizing fasciitis. Recently, a single-center study demonstrated that pharyngeal source of CNF and oral glucocorticoid intake before admission was associated with the occurrence of mediastinitis.

The aim of the study is to assess the incidence and factors associated with CNF complications, in particular mediastinitis. Secondary outcome is to describe patient characteristics, medical and surgical management.

Methods: A retrospective, observational, non-interventional multicentre study is conducted in nine intensive care units in France from January 2005 to December 2016.


Recruitment information / eligibility

Status Recruiting
Enrollment 350
Est. completion date December 2016
Est. primary completion date December 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient admitted in ICU for management of cervical necrotizing fasciitis between 2005 and 2016.

Exclusion Criteria:

- Patients admitted in ICU for management of cervical abscess without cervical necrotizing fasciitis

- Age < 18 years

Study Design

Observational Model: Cohort, Time Perspective: Retrospective


Locations

Country Name City State
France Intensive Care unit, Edouard Herriot Hospital Lyon

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of mediastinitis Computed tomography (CT) is performed at admission. Mediastinitis is described on CT finding. At the entry in ICU (Day 1) No
Secondary factors associated with mediastinitis Computed tomography (CT) is performed at admission. Mediastinitis is described on CT finding. At the entry in ICU (Day 1) No